avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Fos
|
ENSMUSG00000021250.7 | FBJ osteosarcoma oncogene |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Fos | mm10_v2_chr12_+_85473883_85473896 | 0.55 | 5.0e-04 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 21.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
4.2 | 25.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
3.7 | 18.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
3.0 | 9.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
3.0 | 9.1 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
2.7 | 13.3 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
2.6 | 7.8 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
2.5 | 9.8 | GO:1903575 | cornified envelope assembly(GO:1903575) |
2.4 | 7.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
2.1 | 10.7 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
2.1 | 10.4 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
2.1 | 6.2 | GO:0002344 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
1.8 | 9.2 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
1.7 | 3.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
1.7 | 6.8 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
1.4 | 4.1 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
1.3 | 4.0 | GO:0071613 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
1.3 | 11.8 | GO:0032264 | IMP salvage(GO:0032264) |
1.3 | 6.3 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
1.3 | 17.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
1.2 | 6.2 | GO:1905169 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
1.2 | 16.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.2 | 5.9 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
1.1 | 3.2 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
1.1 | 4.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
1.0 | 7.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
1.0 | 20.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.9 | 3.8 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.9 | 3.8 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.9 | 4.4 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.9 | 5.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.8 | 3.3 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.8 | 4.0 | GO:0044805 | late nucleophagy(GO:0044805) |
0.8 | 4.0 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.8 | 4.7 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.7 | 2.2 | GO:0060364 | frontal suture morphogenesis(GO:0060364) |
0.7 | 20.6 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.7 | 7.8 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.6 | 1.9 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.6 | 1.7 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
0.6 | 3.4 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
0.6 | 4.5 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.6 | 1.7 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
0.6 | 9.9 | GO:0006968 | cellular defense response(GO:0006968) |
0.5 | 9.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.5 | 2.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.5 | 3.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.5 | 2.3 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.4 | 2.9 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.4 | 6.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.4 | 4.0 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.4 | 11.7 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.4 | 1.9 | GO:0014826 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) vein smooth muscle contraction(GO:0014826) |
0.4 | 3.4 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.4 | 15.5 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.4 | 2.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.4 | 9.1 | GO:0043486 | histone exchange(GO:0043486) |
0.4 | 16.2 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.3 | 20.0 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.3 | 2.7 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.3 | 2.2 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.3 | 4.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 3.6 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.3 | 2.9 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.3 | 1.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.3 | 3.0 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.3 | 1.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.3 | 3.6 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.3 | 3.1 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.2 | 1.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.7 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.2 | 2.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 2.7 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 7.7 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.2 | 1.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 1.0 | GO:0032329 | serine transport(GO:0032329) |
0.2 | 9.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 1.3 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.2 | 0.6 | GO:0060399 | mineralocorticoid receptor signaling pathway(GO:0031959) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 2.4 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.2 | 4.2 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 0.9 | GO:0030578 | PML body organization(GO:0030578) positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.2 | 4.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.2 | 1.9 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 2.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 5.8 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 4.0 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.1 | 4.3 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 1.4 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.1 | 1.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.5 | GO:0019062 | virion attachment to host cell(GO:0019062) |
0.1 | 3.7 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 1.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 3.8 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 6.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 8.5 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
0.1 | 5.1 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) |
0.1 | 8.4 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 2.0 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 1.0 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 4.2 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.1 | 8.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 1.8 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.1 | 1.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 2.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 3.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.9 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.1 | 4.6 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.1 | 4.0 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.8 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 2.3 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.1 | 0.1 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.1 | 2.4 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 2.0 | GO:0007099 | centriole replication(GO:0007099) |
0.1 | 1.7 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 1.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 2.4 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.7 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.8 | GO:0050774 | enteric nervous system development(GO:0048484) negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 1.2 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 2.4 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.0 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.0 | 0.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 1.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 1.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.2 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 4.7 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.0 | 1.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 1.4 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 4.8 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.0 | 3.1 | GO:0042089 | cytokine biosynthetic process(GO:0042089) |
0.0 | 0.6 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.0 | 0.5 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 3.2 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.2 | GO:1901909 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.0 | 0.7 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 3.2 | GO:0030509 | BMP signaling pathway(GO:0030509) |
0.0 | 1.0 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.9 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 2.6 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.5 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.0 | 0.9 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.0 | 0.4 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 1.7 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.4 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.0 | 1.0 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
0.0 | 0.3 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 0.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 21.1 | GO:0005638 | lamin filament(GO:0005638) |
2.6 | 15.5 | GO:0032437 | cuticular plate(GO:0032437) |
2.5 | 7.4 | GO:0005607 | laminin-2 complex(GO:0005607) |
1.5 | 5.9 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.4 | 4.3 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
1.3 | 4.0 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
1.1 | 9.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.1 | 16.8 | GO:0042581 | specific granule(GO:0042581) |
0.8 | 14.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.8 | 2.4 | GO:1990047 | spindle matrix(GO:1990047) |
0.7 | 2.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.6 | 1.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.6 | 2.5 | GO:0008623 | CHRAC(GO:0008623) |
0.4 | 18.7 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 1.7 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.3 | 2.0 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 5.7 | GO:0042599 | lamellar body(GO:0042599) |
0.3 | 2.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 6.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 2.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 3.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 3.8 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 9.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 4.8 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 5.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.9 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 1.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.1 | 13.2 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 1.4 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.6 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 2.8 | GO:0042627 | low-density lipoprotein particle(GO:0034362) chylomicron(GO:0042627) |
0.1 | 10.4 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 2.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.5 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 21.5 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 1.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 4.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 7.4 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 5.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 3.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 1.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 6.8 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 2.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 10.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 12.5 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 3.1 | GO:0002102 | podosome(GO:0002102) |
0.1 | 6.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 4.0 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 2.7 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 3.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 1.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 1.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 1.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 11.2 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 10.1 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 0.2 | GO:0097444 | spine apparatus(GO:0097444) |
0.1 | 1.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 2.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.5 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 5.1 | GO:0034702 | ion channel complex(GO:0034702) |
0.0 | 1.9 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.1 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 0.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 1.0 | GO:0005844 | polysome(GO:0005844) |
0.0 | 2.4 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 18.7 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
3.9 | 15.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
3.6 | 25.3 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
2.6 | 10.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.6 | 7.9 | GO:0045353 | interleukin-1, Type II receptor binding(GO:0005151) interleukin-1 Type I receptor antagonist activity(GO:0045352) interleukin-1 Type II receptor antagonist activity(GO:0045353) |
2.3 | 11.6 | GO:1990254 | keratin filament binding(GO:1990254) |
2.1 | 10.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.8 | 14.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.8 | 9.1 | GO:0051373 | FATZ binding(GO:0051373) |
1.3 | 11.8 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.0 | 20.9 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
1.0 | 4.0 | GO:0050436 | microfibril binding(GO:0050436) |
0.9 | 4.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.9 | 5.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.7 | 3.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.7 | 4.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.7 | 7.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.6 | 5.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.6 | 2.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.6 | 21.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.6 | 1.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.5 | 9.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.5 | 3.8 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.5 | 2.5 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.5 | 1.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.5 | 3.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.5 | 2.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.5 | 4.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.4 | 1.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.4 | 4.3 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.4 | 5.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 4.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.4 | 6.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.4 | 9.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 7.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 8.7 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 3.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 8.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.3 | 2.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 11.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.3 | 1.7 | GO:0002135 | CTP binding(GO:0002135) |
0.3 | 8.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.3 | 13.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 5.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 9.1 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.3 | 6.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 1.0 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.2 | 5.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 1.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 16.0 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.2 | 4.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 4.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.7 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.2 | 2.9 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.2 | 1.0 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 4.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 1.6 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.2 | 1.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 9.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 4.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.2 | 7.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 3.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 4.2 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 0.9 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.1 | 5.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 2.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.6 | GO:0005143 | growth hormone receptor binding(GO:0005131) interleukin-12 receptor binding(GO:0005143) |
0.1 | 7.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 6.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 3.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 1.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 6.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.6 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 1.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 3.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 2.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 2.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 10.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 3.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 21.2 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 1.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.1 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.1 | 1.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 1.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.9 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 2.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 1.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 5.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 2.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 4.0 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 1.4 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 1.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 3.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 7.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.3 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.0 | 4.4 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 1.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 1.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.2 | GO:0034432 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.0 | 1.3 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 4.0 | GO:0022832 | voltage-gated ion channel activity(GO:0005244) voltage-gated channel activity(GO:0022832) |
0.0 | 5.8 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 1.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 1.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 8.8 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 25.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.7 | 10.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.6 | 9.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.6 | 7.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 28.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 6.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 11.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 1.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 3.4 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 7.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 6.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 7.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 5.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 10.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 7.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 12.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 2.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 2.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 4.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 2.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 7.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 2.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 4.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 10.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 1.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 3.8 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 3.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 4.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 7.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 1.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 2.8 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 3.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 2.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.5 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 0.6 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 3.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 1.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 3.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 2.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 1.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 4.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 11.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.6 | 27.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.5 | 8.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 6.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.4 | 30.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.4 | 16.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.3 | 9.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.3 | 14.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 16.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 3.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 4.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 2.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 3.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 5.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 8.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 3.8 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 2.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 1.7 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 8.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 16.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 5.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 5.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 7.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 6.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 21.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 1.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 7.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 2.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 13.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 6.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 1.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 4.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 2.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 4.4 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 3.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 3.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 3.0 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 1.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 1.0 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 1.7 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.7 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 2.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 1.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.5 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |